Image EMA’s safety committee continues investigation of COVID-19 Vaccine AstraZeneca and thromboembolic events – further update 16 Mar 2021 Press Packagin… EMA is working closely with the company, with experts in blood disorders, and with other health authorities including the UK’s MHRA based on its experience with around 11 million administered doses of the vaccine. Image Read more about EMA’s safety committee continues investigation of COVID-19 Vaccine AstraZeneca and thromboembolic events – further update Log in or register to post comments
